Journal articleMed Care · February 1, 2026
BACKGROUND: Institutions that participate in PCORnet® transform their local electronic health record (EHR) data into the PCORnet® Common Data Model (CDM), which is then used to generate data extracts for PCORnet® Studies. PCORnet® Studies can also include ...
Full textOpen AccessLink to itemCite
Journal articleStroke · October 2025
BACKGROUND: Racial disparities have been reported in stroke care, but understanding if there is regional variability is critical to focusing policies and resources. Here, we sought to study racial and ethnic inequity in the administration of thrombolysis a ...
Full textLink to itemCite
Journal articleLupus Sci Med · August 14, 2025
OBJECTIVE: Using data from participants with paediatric SLE (pSLE) in the Childhood Arthritis and Rheumatology Research Alliance Registry, we aimed to: (1) describe 2-year disease activity trajectories, measured by the SLE Disease Activity Index 2000 (SLED ...
Full textLink to itemCite
Journal articleHome Health Care Management and Practice · May 1, 2025
The Covid-19 pandemic highlighted home healthcare (HHC) as a crucial part of the healthcare industry that faced challenges related to staffing, exposure, and limited access to personal protective equipment. It was unknown how these challenges impacted the ...
Full textCite
Journal articleAm J Prev Cardiol · March 2025
OBJECTIVE: Lowering lipid to reach guideline-indicated goals significantly reduces cardiovascular outcomes in very-high-risk (VHR) patients with atherosclerotic cardiovascular disease (ASCVD) and type 2 diabetes (DM2). How well VHR patients currently achie ...
Full textLink to itemCite
Journal articleInt J Cardiol · February 15, 2025
BACKGROUND: Decisions about stroke prevention strategies in atrial fibrillation (AF) typically balance thromboembolism reduction against increased bleeding from oral anticoagulation therapy (OAC). When determining eligibility for OAC, guidelines recommend ...
Full textLink to itemCite
Journal articleHeart Rhythm · February 2025
BACKGROUND: Implantable cardioverter-defibrillator (ICD) shocks are a common complication after left ventricular assist device (LVAD) implantation; however, data on their frequency and causes are limited. OBJECTIVE: The purpose of this study was to define ...
Full textLink to itemCite
Journal articleCirc Cardiovasc Imaging · February 2025
BACKGROUND: Patients with abnormal (positive) exercise electrocardiography, but normal stress echocardiography (+ECG/-Echo), have an increased risk of adverse cardiovascular events compared with patients with a normal (negative) ECG and a normal stress Ech ...
Full textLink to itemCite
Journal articleAm Heart J · January 2025
BACKGROUND: Reflecting clinical trial data showing improved outcomes with lower LDL-C levels, guidelines across the globe are increasingly recommending a goal of LDL-C <55 mg/dL in persons with atherosclerotic cardiovascular disease (ASCVD). What proportio ...
Full textLink to itemCite
Journal articleJAMA Netw Open · August 1, 2023
IMPORTANCE: Despite momentum for pediatric value-based payment models, little is known about tailoring design elements to account for the unique needs and utilization patterns of children and young adults. OBJECTIVE: To simulate attribution to a hypothetic ...
Full textLink to itemCite
Journal articleArthritis Care Res (Hoboken) · April 2023
OBJECTIVE: Children with well-controlled juvenile idiopathic arthritis (JIA) frequently experience flares after medication discontinuation, but the outcomes of these flares have not been well described. The objective of this study was to characterize the r ...
Full textLink to itemCite
Journal articleArthritis Care Res (Hoboken) · February 2023
OBJECTIVE: To determine the dose-response relationship of tumor necrosis factor (TNF) inhibition in the treatment of juvenile idiopathic arthritis (JIA). METHODS: Participants of the Childhood Arthritis and Rheumatology Research Alliance Registry were elig ...
Full textLink to itemCite
Journal articleRheumatology (Oxford) · February 1, 2023
OBJECTIVE: To describe 2-year trajectories of the clinical Juvenile Arthritis Disease Activity Score, 10 joints (cJADAS10) and associated baseline characteristics in patients with JIA. METHODS: JIA patients in the Childhood Arthritis and Rheumatology Resea ...
Full textLink to itemCite
Journal articleHeart Rhythm O2 · December 2022
BACKGROUND: Oral anticoagulation (OAC) reduces the risk of thromboembolic events in patients with atrial fibrillation (AF); however, thromboembolism (TE) still can occur despite OAC. Factors associated with residual risk for stroke, systemic embolism, or t ...
Full textLink to itemCite
Journal articleArthritis care & research · November 2022
ObjectiveTo describe high-dose biologic use when treating juvenile idiopathic arthritis (JIA).MethodsPatients with JIA enrolled in the Childhood Arthritis and Rheumatology Research Alliance Registry and treated with a biologic after enrol ...
Full textCite
Journal articleAm Heart J · February 2022
BACKGROUND: Burden of atrial fibrillation (AF), as a continuous measure, is an emerging alternative classification often assumed to increase linearly with progression of disease. Yet there are no descriptions of AF burden distributions across populations. ...
Full textLink to itemCite
Journal articleBMC Health Serv Res · October 25, 2021
BACKGROUND AND OBJECTIVE: To characterize health care use and costs among new Medicaid enrollees before and during the COVID pandemic. Results can help Medicaid non-expansion states understand health care use and costs of new enrollees in a period of enrol ...
Full textLink to itemCite
Journal articleJ Pediatr · February 2021
OBJECTIVE: To describe enrollment characteristics of youth in the Cascade Screening for Awareness and Detection of FH Registry. STUDY DESIGN: This is a cross-sectional analysis of 493 participants aged <18 years with heterozygous familial hypercholesterole ...
Full textLink to itemCite
Journal articleCleft Palate Craniofac J · November 2020
OBJECTIVE: To characterize operative care for cleft lip and/or palate (CL/P) based on location (ie, from American Cleft Palate Craniofacial Association [ACPA]-approved multidisciplinary teams or from community providers). DESIGN: Cross-sectional analysis o ...
Full textOpen AccessLink to itemCite
Journal articleHealth Aff (Millwood) · October 2020
Using North Carolina Medicaid 2016-18 claims data, we found that approximately one in ten adolescents (10.8 percent) filled at least one opioid prescription per year. Dentists, advanced practice providers, and surgeons were common prescribers of opioids to ...
Full textLink to itemCite
Journal articleAm Heart J · February 2020
BACKGROUND: Amiodarone is the most effective antiarrhythmic drug (AAD) for atrial fibrillation (AF), but it has a high incidence of adverse effects. METHODS: Using the ORBIT AF registry, patients with AF on amiodarone at enrollment, prescribed amiodarone d ...
Full textLink to itemCite
Journal articleAm Heart J · January 2020
BACKGROUND: Comorbidities are common in patients with atrial fibrillation (AF) and affect prognosis, yet are often undertreated. However, contemporary rates of use of guideline-directed therapies (GDT) for non-AF comorbidities and their association with ou ...
Full textLink to itemCite
Journal articleCirculation. Arrhythmia and electrophysiology · December 2019
BackgroundStudies evaluating the effects of atrial fibrillation (AF) catheter ablation versus antiarrhythmic therapy on outcomes have shown mixed results. In addition, guidelines recommend continuing oral anticoagulation (OAC) after ablation for t ...
Full textCite
Journal articleCardiol Young · October 2019
BACKGROUND: While echocardiographic parameters are used to quantify ventricular function in infants with single ventricle physiology, there are few data comparing these to invasive measurements. This study correlates echocardiographic measures of diastolic ...
Full textLink to itemCite
Journal articleAtherosclerosis · October 2019
BACKGROUND AND AIMS: There are limited data from the US on outcomes of patients in specialty care for familial hypercholesterolemia (FH). METHODS: CASCADE FH Registry data were analyzed to assess longitudinal changes in medication usage, in low density lip ...
Full textLink to itemCite
Journal articleJournal of clinical lipidology · September 2019
BackgroundTrials have demonstrated that proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors are effective as an adjunct to statin therapy, but access and cost issues have limited their use in community practice.ObjectiveThe a ...
Full textCite
Journal articleAm Heart J · July 2019
BACKGROUND: Treatment patterns and outcomes of individuals with vascular disease who have new-onset atrial fibrillation (AF) are not well characterized. METHODS: Among patients with new-onset AF, we analyzed treatment and outcomes in those with or without ...
Full textLink to itemCite
Journal articleJ Am Heart Assoc · May 7, 2019
Background Patient satisfaction with therapy is an important metric of care quality and has been associated with greater medication persistence. We evaluated the association of patient satisfaction with warfarin therapy to other metrics of anticoagulation ...
Full textLink to itemCite
Journal articleJ Thromb Thrombolysis · November 2018
Anticoagulation is highly effective for the prevention of stroke in patients with atrial fibrillation (AF) but it is dependent on patients continuing therapy. While studies have demonstrated suboptimal therapeutic persistence on warfarin, few have studied ...
Full textLink to itemCite
Journal articleJ Am Heart Assoc · April 13, 2018
BACKGROUND: Mineralocorticoid receptor antagonist (MRA) therapy may be beneficial to patients with atrial fibrillation (AF), but little is known about their use in patients with AF and subsequent outcomes. METHODS AND RESULTS: In order to better understand ...
Full textLink to itemCite
Journal articleJ Am Heart Assoc · February 16, 2018
BACKGROUND: Non-vitamin K antagonist oral anticoagulants (NOACs) are indicated for stroke prevention in atrial fibrillation (AF) but require lower doses in certain patients. We sought to describe the frequency, appropriateness (according to Food and Drug A ...
Full textLink to itemCite
Journal articleJAMA Cardiol · January 1, 2018
IMPORTANCE: Atrial fibrillation (AF) is usually classified on the basis of the disease subtype. However, this characterization does not capture the full heterogeneity of AF, and a data-driven cluster analysis reveals different possible classifications of p ...
Full textLink to itemCite
Journal articleJ Am Heart Assoc · December 22, 2017
BACKGROUND: The presence of valvular heart disease (VHD) may affect the risk of stroke and mortality in patients with atrial fibrillation (AF). Community-based estimates of prevalence and outcomes of specific forms of VHD in patients with AF are lacking. M ...
Full textLink to itemCite
Journal articleAm Heart J · December 2017
UNLABELLED: Atrial fibrillation (AF) is the most common cardiac arrhythmia in the world. We aimed to provide comprehensive data on international patterns of AF stroke prevention treatment. METHODS: Demographics, comorbidities, and stroke risk of the patien ...
Full textLink to itemCite
Journal articleAtherosclerosis · December 2017
BACKGROUND AND AIMS: Most familial hypercholesterolemia (FH) patients remain undertreated, and it is unclear what role health disparities may play for FH patients in the US. We sought to describe sex and racial/ethnic disparities in a national registry of ...
Full textLink to itemCite
Journal articleJ Am Coll Cardiol · September 12, 2017
BACKGROUND: Diabetes is a well-established risk factor for thromboembolism in patients with atrial fibrillation (AF), but less is known about how diabetes influences outcomes among AF patients. OBJECTIVES: This study assessed whether symptoms, health statu ...
Full textLink to itemCite
Journal articleEuropace · July 1, 2017
AIMS: Antiarrhythmic medications for the treatment of atrial fibrillation (AF) have limited efficacy and rare but potentially life-threatening side effects. Ranolazine is an antianginal agent that may have antiarrhythmic activity in AF. METHODS AND RESULTS ...
Full textLink to itemCite
Journal articleAm Heart J · July 2017
BACKGROUND: Several non-vitamin K antagonist oral anticoagulant (NOAC) alternatives to warfarin are available for stroke prevention in atrial fibrillation (AF). We aimed to describe the factors associated with selection of NOACs versus warfarin in patients ...
Full textLink to itemCite
Journal articleEur Heart J Qual Care Clin Outcomes · July 1, 2017
AIMS: The presence of cancer can complicate treatment choices for patients with atrial fibrillation (AF) increasing both the risk of thrombotic and bleeding events. METHODS AND RESULTS: Using data from Outcomes Registry for Better Informed Treatment of Atr ...
Full textOpen AccessLink to itemCite
Journal articleAm J Cardiol · June 1, 2017
The degree to which clinical outcomes are worsened in patients with atrial fibrillation (AF) with heart failure (HF) compared with those without HF is not well described. This study aimed to determine the impact of HF on clinical outcomes in patients with ...
Full textLink to itemCite
Journal articleJ Am Coll Cardiol · December 20, 2016
BACKGROUND: Although non-vitamin K antagonist oral anticoagulants (NOACs) do not require frequent laboratory monitoring, each compound requires dose adjustments on the basis of certain clinical criteria. OBJECTIVES: This study assessed the frequency of off ...
Full textLink to itemCite
Journal articleAm J Cardiol · December 1, 2016
Associations of early creatine phosphokinase-MB (CK-MB) elevation and new Q waves and their association with cardiovascular death (CVD) after coronary artery bypass grafting (CABG) have been reported, but this association has not been studied in a large po ...
Full textLink to itemCite
Journal articleAm Heart J · November 2016
BACKGROUND: Assessments of stroke and bleeding risks are essential to selecting oral anticoagulation in patients with atrial fibrillation (AF). We aimed to assess outcomes according to physician assessed risk, with comparison to empirical risk scores. METH ...
Full textLink to itemCite
Journal articleCirc Cardiovasc Genet · June 2016
BACKGROUND: Cardiovascular disease burden and treatment patterns among patients with familial hypercholesterolemia (FH) in the United States remain poorly described. In 2013, the FH Foundation launched the Cascade Screening for Awareness and Detection (CAS ...
Full textLink to itemCite
Journal articleJACC Clin Electrophysiol · June 2016
OBJECTIVES: This study sought to determine the association between body mass index (BMI) and clinical outcomes among patients with prevalent atrial fibrillation (AF). BACKGROUND: Higher BMI is an independent risk factor for incident AF. However, its impact ...
Full textLink to itemCite
Journal articleJACC Clin Electrophysiol · April 2016
OBJECTIVES: The study sought to evaluate clinical outcomes in clinical practice with rhythm control versus rate control strategy for management of atrial fibrillation (AF). BACKGROUND: Randomized trials have not demonstrated significant differences in stro ...
Full textLink to itemCite
Journal articleJ Pediatr · March 2016
OBJECTIVES: To assess self-reported quality of life (QOL) in a large multicenter cohort of adolescent and young adults surviving Fontan. STUDY DESIGN: Cross-sectional. The Pediatric Quality of Life Inventory (PedsQL) was administered to 408 survivors of Fo ...
Full textLink to itemCite
Journal articleJ Pediatr · January 2016
OBJECTIVE: To assess the variability in asymmetric growth and its association with neurodevelopment in infants with single ventricle (SV). STUDY DESIGN: We analyzed weight-for-age z-score minus head circumference-for-age z-score (HCAZ), relative head growt ...
Full textLink to itemCite
Journal articleJ Clin Lipidol · 2016
BACKGROUND: In the US familial hypercholesterolemia (FH), patients are underidentified, despite an estimated prevalence of 1:200 to 1:500. Criteria to identify FH patients include Simon Broome, Dutch Lipid Clinic Network (DLCN), or Make Early Diagnosis to ...
Full textLink to itemCite
Journal articleThe American journal of cardiology · May 2015
This study assesses demographic and clinical variables associated with perioperative and late stroke in diabetes mellitus patients after multivessel coronary artery bypass grafting (CABG). Future Revascularization Evaluation in Patients with Diabetes Melli ...
Full textCite
Journal articleCongenit Heart Dis · 2015
OBJECTIVE: Multicenter longitudinal outcome data for Fontan patients surviving into adulthood are lacking. The aim of this study was to better understand contemporary outcomes in Fontan survivors by collecting follow-up data in a previously well-characteri ...
Full textLink to itemCite
Journal articleJ Thorac Cardiovasc Surg · October 2014
OBJECTIVE: To compare the interstage cardiac catheterization hemodynamic and angiographic findings between shunt types for the Pediatric Heart Network Single Ventricle Reconstruction trial. The trial, which randomized subjects to a modified Blalock-Taussig ...
Full textLink to itemCite
Journal articlePLoS Genet · August 2014
Type 2 diabetes (T2D) is more prevalent in African Americans than in Europeans. However, little is known about the genetic risk in African Americans despite the recent identification of more than 70 T2D loci primarily by genome-wide association studies (GW ...
Full textLink to itemCite
Journal articleInternational journal of paediatric dentistry · May 2014
ObjectiveResins used in dental composites, derived from bisphenol-A (BPA), have been shown to alter immune cells. The objective of this study was to explore children's immune function changes in relation to resin composite treatment.Design
Full textCite
Journal articlePediatr Cardiol · April 2014
Despite hypothesized concerns about deterioration beginning in adolescence, longitudinal data and associated factors regarding standardized assessment of physical functioning are not available for Fontan patients. Parents who participated in the Fontan Cro ...
Full textLink to itemCite
Journal articleObesity (Silver Spring) · March 2014
OBJECTIVE: The association of familial as compared to genetic factors in the current obesogenic environment, compared with earlier, leaner time periods, is uncertain. METHODS: Participants from the Framingham Heart Study were classified according to parent ...
Full textLink to itemCite
Journal articleBritish dental journal · January 2014
ObjectiveTo examine whether greater exposure to resin-based composite materials, which may intra-orally release bisphenol A (BPA), is associated with worse renal function outcomes in children.DesignProspective multi-centre study.Setti ...
Full textCite
Journal articlePediatric dentistry · January 2014
PurposeDental sealant materials may intraorally release their components, including bisphenol-A (BPA), but long-term health effects are uncertain. The New England Children's Amalgam Trial (NECAT) found that composite restorations were associated w ...
Cite
Journal articleBritish dental journal · January 2014
ObjectiveTo examine whether greater exposure to resin-based composite materials, which may intra-orally release bisphenol A (BPA), is associated with worse renal function outcomes in children.DesignProspective multi-centre study.Setti ...
Full textCite
Journal articleCirc Heart Fail · November 2013
BACKGROUND: Despite medical advances, children with dilated cardiomyopathy (DCM) remain at high risk of death or need for cardiac transplantation. We sought to identify predictors of disease progression in pediatric DCM. METHODS AND RESULTS: The Pediatric ...
Full textLink to itemCite
Journal articleDiabetes care · January 2013
ObjectiveTo identify the most important pretreatment characteristics and changes in psychological and behavioral factors that predict weight outcomes in the Diabetes Prevention Program (DPP).Research design and methodsApproximately 25% of ...
Full textCite
Journal articleJournal of dental research · November 2012
Resin-based composite dental restoration materials may release bisphenol-A, an endocrine-disrupting chemical. Using secondary analysis of a randomized clinical safety trial of amalgam vs. composites, we tested the hypothesis that dental restoration materia ...
Full textCite
Journal articleNeurotoxicology · October 2012
BackgroundResin-based dental restorations may intra-orally release their components and bisphenol A. Gestational bisphenol A exposure has been associated with poorer executive functioning in children.ObjectivesTo examine whether exposure ...
Full textCite
Journal articleJ Thorac Cardiovasc Surg · October 2012
OBJECTIVES: The Single Ventricle Reconstruction trial randomized 555 subjects with a single right ventricle undergoing the Norwood procedure at 15 North American centers to receive either a modified Blalock-Taussig shunt or right ventricle-to-pulmonary art ...
Full textLink to itemCite
Journal articlePediatrics · August 2012
Background and objectiveResin-based dental materials may intraorally release their chemical components and bisphenol A. The New England Children's Amalgam Trial found that children randomized to amalgam had better psychosocial outcomes than those ...
Full textCite
Journal articleDiabetes · June 2012
Common genetic risk variants for type 2 diabetes (T2D) have primarily been identified in populations of European and Asian ancestry. We tested whether the direction of association with 20 T2D risk variants generalizes across six major racial/ethnic groups ...
Full textCite
Journal articleDiabetes · May 2012
Gene-lifestyle interactions have been suggested to contribute to the development of type 2 diabetes. Glucose levels 2 h after a standard 75-g glucose challenge are used to diagnose diabetes and are associated with both genetic and lifestyle factors. Howeve ...
Full textCite
Journal articleAm J Cardiol · March 1, 2012
Little is known about the familial aggregation of intermittent claudication (IC). Our objective was to examine whether parental IC increased the risk of IC in adult offspring, independent of the established cardiovascular risk factors. We evaluated the Off ...
Full textLink to itemCite
Journal articlePLoS One · 2012
African Americans are disproportionately affected by type 2 diabetes (T2DM) yet few studies have examined T2DM using genome-wide association approaches in this ethnicity. The aim of this study was to identify genes associated with T2DM in the African Ameri ...
Full textLink to itemCite
Journal articleMetabolic syndrome and related disorders · December 2011
BackgroundElevated insulin resistance (IR), triglycerides (TG), body mass index (BMI), and waist circumference (WC) are features of the metabolic syndrome. Although several single-nucleotide polymorphisms (SNPs) associated with these traits have b ...
Full textCite
Journal articleNat Genet · October 16, 2011
Concentrations of liver enzymes in plasma are widely used as indicators of liver disease. We carried out a genome-wide association study in 61,089 individuals, identifying 42 loci associated with concentrations of liver enzymes in plasma, of which 32 are n ...
Full textLink to itemCite
Journal articleObesity (Silver Spring, Md.) · October 2011
Inhibition of the endocannabinoid receptor CB1 improves insulin sensitivity, lowers glycemia, and slows atherosclerosis. We analyzed whether common variants in the gene encoding CB1, CNR1, are associated with insulin resistance, risk of type 2 diabetes (T2 ...
Full textCite
Journal articleDiabetes research and clinical practice · August 2011
ObjectiveParental history of diabetes and specific gene variants are risk factors for type 2 diabetes, but the extent to which these factors are associated is unknown.MethodsWe examined the association between parental history of diabetes ...
Full textCite
Journal articleDiabetologia · May 2011
Aims/hypothesisLower adiponectin levels are associated with higher risk of incident type 2 diabetes. Most analyses have been adjusted for confounding factors, but few have taken into account insulin resistance per se. We tested the hypothesis that ...
Full textCite
Journal articlePLoS Genet · February 10, 2011
Coronary heart disease (CHD) is the leading cause of mortality in African Americans. To identify common genetic polymorphisms associated with CHD and its risk factors (LDL- and HDL-cholesterol (LDL-C and HDL-C), hypertension, smoking, and type-2 diabetes) ...
Full textLink to itemCite
Journal articleObesity (Silver Spring, Md.) · February 2011
Adiponectin and resistin's possible roles in weight regulation have received little attention. We tested the hypothesis that adipokine levels predict future weight gain in women in the Nurses' Health Study. Among women who provided blood samples in 1990, w ...
Full textCite
Journal articleDiabetes Care · January 2011
OBJECTIVE: To test if knowledge of type 2 diabetes genetic variants improves disease prediction. RESEARCH DESIGN AND METHODS: We tested 40 single nucleotide polymorphisms (SNPs) associated with diabetes in 3,471 Framingham Offspring Study subjects followed ...
Full textLink to itemCite
Journal articleDiabetes · December 2010
OBJECTIVE: Glycated hemoglobin (HbA₁(c)), used to monitor and diagnose diabetes, is influenced by average glycemia over a 2- to 3-month period. Genetic factors affecting expression, turnover, and abnormal glycation of hemoglobin could also be associated wi ...
Full textLink to itemCite
Journal articleDiabetes care · November 2010
ObjectiveTo estimate allele frequencies and the marginal and combined effects of novel fasting glucose (FG)-associated single nucleotide polymorphisms (SNPs) on FG levels and on risk of impaired FG (IFG) among non-Hispanic white, non-Hispanic blac ...
Full textCite
Journal articleDiabetes care · October 2010
ObjectiveTo determine whether an electronic order template for basal-bolus insulin ordering improves mean blood glucose in hospitalized general medical patients with hyperglycemia and type 2 diabetes.Research design and methodsWe randomly ...
Full textCite
Journal articleNature genetics · July 2010
By combining genome-wide association data from 8,130 individuals with type 2 diabetes (T2D) and 38,987 controls of European descent and following up previously unidentified meta-analysis signals in a further 34,412 cases and 59,925 controls, we identified ...
Full textCite
Journal articleDiabetes · May 2010
OBJECTIVE Recent genome-wide association studies have revealed loci associated with glucose and insulin-related traits. We aimed to characterize 19 such loci using detailed measures of insulin processing, secretion, and sensitivity to help elucidate their ...
Full textCite
Journal articleMetabolism: clinical and experimental · April 2010
Tumor necrosis factor alpha (TNFalpha) is a proinflammatory adipokine hypothesized to link obesity with insulin resistance. Functional studies suggest that TNFalpha acts through pathways involving adipokines and fatty acids to induce insulin resistance. We ...
Full textCite
Journal articleNature genetics · February 2010
Glucose levels 2 h after an oral glucose challenge are a clinical measure of glucose tolerance used in the diagnosis of type 2 diabetes. We report a meta-analysis of nine genome-wide association studies (n = 15,234 nondiabetic individuals) and a follow-up ...
Full textCite
Journal articleNature genetics · February 2010
Levels of circulating glucose are tightly regulated. To identify new loci influencing glycemic traits, we performed meta-analyses of 21 genome-wide association studies informative for fasting glucose, fasting insulin and indices of beta-cell function (HOMA ...
Full textCite
Journal articleDiabetes care · October 2009
ObjectiveTo examine perceived risk of developing diabetes in primary care patients.Research design and methodsWe recruited 150 nondiabetic primary care patients. We made standard clinical measurements, collected fasting blood samples, and ...
Full textCite
Journal articleDiabetologia · October 2009
Aims/hypothesisThe pathophysiology of type 2 diabetes involves pro-inflammatory pathways. We tested the hypothesis that IL-18 predicts future diabetes cases.MethodsWe used a nested case-control design based in the Nurses' Health Study. Ba ...
Full textCite
Journal articleBMC health services research · September 2009
BackgroundPrevention of diabetes and coronary heart disease (CHD) is possible but identification of at-risk patients for targeting interventions is a challenge in primary care.MethodsWe analyzed electronic health record (EHR) data for 122 ...
Full textCite
Journal articleClinica chimica acta; international journal of clinical chemistry · August 2009
BackgroundDiabetes mellitus is a major risk factor for coronary heart disease (CHD), renal failure, retinopathy, and neuropathy. Lowering glycosylated hemoglobin (HbA1c) as well as low-density lipoprotein-cholesterol (LDL-C) has been associated wi ...
Full textCite
Journal articleThe New England journal of medicine · November 2008
BackgroundMultiple genetic loci have been convincingly associated with the risk of type 2 diabetes mellitus. We tested the hypothesis that knowledge of these loci allows better prediction of risk than knowledge of common phenotypic risk factors al ...
Full textCite
Journal articleAm J Public Health · July 2008
OBJECTIVES: We sought to determine change in the prevalence of functional limitations and physical disability among the community-dwelling elderly population across 3 decades. METHODS: We studied original participants of the Framingham Heart Study, aged 79 ...
Full textLink to itemCite